Author: Robert Chong
Editor: Adrian Fung
A 21-year-old male presented with floaters in his right eye.
An otherwise healthy 21-year-old male student from Bangladesh presented with sudden onset of reduced vision and floaters in his right eye. He was not taking any medications. Examination showed reduced vision of 6/18 on the right (OD) and 6/6 on the left (OS). In the right eye there were vitreous cells, retinal haemorrhages, pre-retinal haemorrhage from retinal neovascularization, cotton wool spots and sheathing of retinal vessels (Figure 1). The left eye was normal.
What is your diagnosis?
His clinical picture is consistent with an ischaemic branch retinal vein occlusion (BRVO). Risk factors of a BRVO include1,2:
- Systemic vascular disease – Hypertension, diabetes, hypercholesterolemia, smoking, obesity
- Glaucoma (although studies on this are inconsistent as to whether this is a risk factor)
In younger patients, the following risk factors should also be considered:
- Haematologic – hyperviscosity and prothrombotic conditions
- Inflammatory – retinal vasculitis
Atypical features of this vein occlusion are the young age of the patient and the absence of vascular risk factors. The presence of vitritis and vascular sheathing suggested an inflammatory cause.
Fluorescein angiography showed an ischaemic BRVO with retinal neovascularisation and peripheral retinal ischaemia (Figure 2). There was late fluorescein leakage at the macula and optic disc. Optical coherence tomography (OCT) showed moderate cystoid macular oedema at the temporal margin of the fovea (Figure 3).
Investigations (FBC, UEC, fasting BSL, lipid profile, syphilis serology, ACE, HIV serology, ESR, CRP, rheumatoid factor, ANA, ANCA, hepatitis serology and chest X-ray) were ordered looking for an underlying inflammatory cause to the BRVO. As the patient was from a tuberculosis (TB) endemic area (Bangladesh), a Quantiferon Gold TB Assay was ordered and returned positive (TB specific antigen 0.77IU/ml, mitogen 1.55 IU/ml). The patient was promptly referred to a respiratory physician who felt that the probability of latent TB was high. Full anti-tuberculous medication (9 months of rifampicin, ethambutol, isoniazid and pyrazinamide) was prescribed.
Oral prednisone (75mg) was commenced in addition to the anti-tuberculous treatment to stem the inflammatory drive. Scatter argon laser photocoagulation was applied to areas of ischaemic retina. Despite this, a small vitreous haemorrhage developed from the retinal neovascularization. With further laser and a slow taper of his steroids the patient made good progress with resolution of the retinal vasculitis and macular oedema and improvement of the vitreous haemorrhage (Figure 4). Two months after commencing treatment, the vision improved to 6/9 OD.
Tuberculosis affecting the eye can present in a number of ways, including: eyelid, orbital, conjunctival or choroidal granulomas, scleritis, keratitis, anterior uveitis, multifocal choroiditis with vitritis and chorioretinitis, tuberculous serpiginouslike choroiditis, neuroretinitis and retinal vasculitis.3,4 Retinal vasculitis, as in this case, often affects the veins (periphlebitis) and can cause a vein occlusion. The pathophysiology of the vasculitis is thought be to be a hypersensitivity reaction to the Mycobacterium tuberculosis bacilli, although direct infection cannot be excluded. Treatment involves a long course (usually 6-9 months) of anti-tuberculosis therapy prescribed by a respiratory physician. Systemic steroids may be added but only as an adjunct to anti-tuberculosis treatment as steroids alone may exacerbate TB infection resulting in reactivation of miliary tuberculosis.5
Take home points
1. Anonymous. Risk factors for branch retinal vein occlusion. Arch Ophthalmol 1993;116(3):286-96.
2. Yoaum DJ, Ha MM, Chang Y, Song SJ. Retinal Vessel Caliber and Risk Factors for Branch Retinal Vein Occlusion. Curr Eye Res 2012; 37(4):334-48.
3. Tabbara KF. Tuberculosis. Curr Opin Ophthalmol 2007;18:493-501.
4. Helm C, Holland G. Ocular tuberculosis. Surv Ophthalmol 1993;38:229-251.
5. A Gupta, V Gupta: Tubercular posterior uveitis. Int Ophthalmol Clin. 2005,45:71-88.
Care has been taken to confirm the accuracy of the information present and to describe generally accepted practices. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of the publication. Application of this information in a particular situation remains the professional responsibility of the practitioner; the clinical treatments described and recommended may not be considered absolute and universal recommendations.